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ABSTRACT Asthma is a common cause of emergency care attendance in low- and middle-income
countries (LMICs). While few prospective studies of predictors for emergency care attendance have been
undertaken in high-income countries, none have been performed in a LMIC.
We followed a cohort of 5–15-year-old children treated for asthma attacks in emergency rooms of
public health facilities in Esmeraldas City, Ecuador. We collected blood and nasal wash samples, and
performed spirometry and exhaled nitric oxide fraction measurements. We explored potential predictors
for recurrence of severe asthma attacks requiring emergency care over 6 months’ follow-up.
We recruited 283 children of whom 264 (93%) were followed-up for ⩾6 months or until their next
asthma attack. Almost half (46%) had a subsequent severe asthma attack requiring emergency care.
Predictors of recurrence in adjusted analyses were (adjusted OR, 95% CI) younger age (0.87, 0.79–0.96 per
year), previous asthma diagnosis (2.2, 1.2–3.9), number of parenteral corticosteroid courses in previous
year (1.3, 1.1–1.5), food triggers (2.0, 1.1–3.6) and eczema diagnosis (4.2, 1.02–17.6). A parsimonious Cox
regression model included the first three predictors plus urban residence as a protective factor (adjusted
hazard ratio 0.69, 95% CI 0.50–0.95). Laboratory and lung function tests did not predict recurrence.
Factors independently associated with recurrent emergency attendance for asthma attacks were
identified in a low-resource LMIC setting. This study suggests that a simple risk-assessment tool could
potentially be created for emergency rooms in similar settings to identify higher-risk children on whom
limited resources might be better focused.
This article has supplementary material available from erj.ersjournals.com
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Introduction
Severe asthma attacks requiring emergency care, hospital admission or systemic corticosteroids [1] are a
common source of preventable morbidity in children. Asthma attacks are associated with impaired lung
function [2], anxiety in patients and families [3] and elevated healthcare and family costs [4]. Many
asthma attacks are preventable, either by avoiding triggers or by appropriate preventive treatment. Inhaled
corticosteroids (ICS) reduce the probability of asthma attacks by ∼40% [5] and can attenuate the decline
in lung function associated with asthma attacks [2]. Because ICS have associated side-effects [6–8] and
costs, use should be targeted at those at greater risk of attacks or persistent symptoms, especially when
resources are limited. Identifying children with a greater risk of asthma attacks is crucial for optimisation
of asthma treatment, particularly in low-resource settings where under-diagnosis and lack of capacity for
long-term management are major problems.
In most Latin American countries where health resources and specialist follow-up care are limited [9, 10],
children with asthma are mainly seen in emergency rooms (ER) during acute attacks [11, 12]. The ER
represents an opportunity to identify children at higher risk of future attacks. Factors that have been
associated previously with recurrent asthma attacks requiring emergency care in paediatric cohort studies
include history of previous ER attendance for attacks, younger age, black ethnicity and low socioeconomic
status [13–16]. However, these studies were undertaken almost exclusively in North America and did not
evaluate potential usefulness of biomarkers commonly available in higher-income settings [16]. No
prospective studies investigating ER re-attendance for asthma from lower-income settings were identified
in a recent systematic review [16].
We undertook a prospective cohort study to identify clinical factors and biomarkers associated with
recurrent severe asthma attacks in children presenting with an asthma attack at regional ERs in a
limited-resource setting in Latin America.
Methods
Study population and design
This prospective cohort study was done in the city of Esmeraldas, Ecuador (population 150000, of mainly
Afro-Ecuadorian ethnicity) in the north-western coastal province of Esmeraldas. Patients were recruited
from the city’s public hospital, Delfina Torres de Concha Hospital, which offers free attention and
treatment; the Instituto Ecuatoriano de Seguro Social Esmeraldas hospital, which offers free treatment to
those paying national insurance; and the three largest public health centres in the city with 24-h
emergency care.
Children aged 5–15 years treated at emergency departments for asthma attacks (defined as
bronchodilator-responsive wheeze) were recruited between May 2014 and September 2015. Children with
other chronic conditions were excluded. Written consent was obtained from the child’s caregiver and
minor assent from children aged >7 years. A total of 283 children were recruited. The protocol was
approved by the bioethics committees of the Liverpool School of Tropical Medicine (Liverpool, UK) and
the Universidad San Francisco de Quito (Quito, Ecuador).
Measurements of exposures and outcomes
Data were collected in Spanish from the child’s caregiver using a modified version of the International
Study of Asthma and Allergies in Childhood (ISAAC) phase II questionnaire [17], which has been
extensively field-tested [18, 19], together with additional questions regarding potential risk factors for
recurring asthma attacks. A detailed description of variables studied is included in supplementary table S1.
The Childhood Asthma Control Test (C-ACT) [20] was completed by the child and guardian for children
aged <12 years or the ACT [21] for those aged ⩾12 years. Weight and height were measured. A blood
sample was drawn for haematocrit, blood count and plasma assays. Total and specific (s)IgE for
Dermatophagoides pteronyssinus and Blomia tropicalis were measured using the CAP system (Pharmacia
Diagnostics, Uppsala, Sweden) in 86 random plasma samples, of which 60 were tested for German
cockroach and food mix (egg white, milk, cod, wheat, peanut, soy)-specific IgE. A positive assay for sIgE
was defined as >0.70 kU·L−1. A nasal wash with saline was performed to determine the relative proportion
of granulocytes (eosinophils versus neutrophils) using a protocol modified from a previous study [22] (see
the supplementary material for detailed technique). Participants returned 2 weeks after recruitment (or up
to 3 weeks if during the 2-week appointment they were still taking daily salbutamol or oral corticosteroids
or had wheezing) for pre- and post-bronchodilator spirometry (MicroLoop spirometer, Micro Direct,
Lewiston, ME, USA) and exhaled nitric oxide fraction (FeNO) (NObreath; Bedfont Scientific, Maidstone,
UK). At this time, the Paediatric Asthma Quality of Life Questionnaire (PAQLQ) [23] and Newcastle
Asthma Knowledge Questionnaire (NAKQ) [24, 25] were completed. Asthma severity was classified using
the Ecuadorian Asthma Consensus 2011 [26], which closely follows the Global Initiative for Asthma
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(GINA) 2008 [27] and Spanish 2009 asthma guidelines [28]. Participants were offered inhaled β2-agonists
as relievers with or without corticosteroids for long-term treatment in accordance with these guidelines. In
addition, they were provided with a standardised short education on asthma, recommendations for future
asthma attacks and written asthma action plans.
Each participant was followed-up with twice-monthly telephone calls asking about asthma attacks
(number, severity, duration and treatment received) and told to contact the study team immediately
following an attack. A severe asthma attack was defined as an acute exacerbation of respiratory symptoms
(difficulty breathing and wheezing that improved with bronchodilators) requiring either 1) urgent care at
an ER or 2) unscheduled medical visit with prescription of systemic corticosteroids (for ⩾3 days if oral)
[1]. Hospital and health centre records were checked twice weekly to record unscheduled visits for attacks.
Statistical analysis
The primary outcome was recurrence of an asthma attack requiring emergency care and occurring
between 2 weeks and 6 months after the index attack. Only the first recurrence was considered in the
analysis among those with more than one attack during follow-up. Only variables measured at baseline
were studied as risk factors. Continuous variables were compared using t-tests or Mann–Whitney U-tests,
as appropriate. Categorical variables were compared using Fisher’s exact test. Multivariable logistic
regression was used to evaluate the effects of multiple risk factors for emergency care re-attendance on risk
of recurrence of asthma attacks. Only children followed-up until their first asthma attack recurrence or for
a minimum of 6 months exacerbation-free were included in this analysis. A time-to-event analysis was
performed using a multivariable Cox proportional hazard model, including all children who completed
⩾2 weeks of follow-up. Collett’s method of variable selection [29] was used with a p-value threshold of 0.2,
and confounding and interactions between variables were assessed. The parsimonious logistic and Cox
models were selected based on explained variation (R2). The proportional hazards assumption required by
the Cox model was tested via the inclusion of time-dependent variables. The assumption was valid for all
included variables.
The predictive ability of the models was evaluated by estimating the area under the receiver operating
characteristics curve (AUC) [30] and its 95% confidence interval, with 0.5 indicating a model with no
discriminating power and 1.0 a perfectly discriminating model [31]. Internal validity was then assessed by
bootstrapping using 200 random bootstrap samples with replacement, to evaluate potential bias (over- or
under-fitting). Optimism in regression coefficients due to overfitting was estimated by measuring the
difference between the model’s c-statistic (apparent c-statistic) and the c-statistic computed by
nonparametric bootstrap resampling (internal bootstrap validation c-statistic) [32].
Statistical analyses were performed using Stata 13.1 with significance set at p<0.05. Details of sample size
calculations and missing data strategy are provided in the supplementary material.
Results
Out of the 283 children recruited, 13 (4.6%) were lost to follow-up after the initial visit, and 264 (93%)
were followed-up until their next asthma attack or a minimum of 6 months exacerbation-free. Of these,
121 (46%) had at least one subsequent asthma attack requiring emergency care during the first 6 months
of follow-up (figure 1). The median follow-up time was 408 days (interquartile range (IQR) 265–541 days,
range 44–697 days) and the median time to a subsequent asthma exacerbation was 91 days (IQR 39–
178 days). Figure 2 shows time to first recurrence of a severe asthma attack.
Tables 1 and 2 show characteristics for the 264 children completing 6 months’ follow-up or until first
asthma attack recurrence, stratified by re-admission status at 6 months’ follow-up. Available data for each
variable are shown in supplementary table S1. Data for allergy and inflammatory markers and lung
function are shown in figure 3. 39% (107 out of 272) of all children had blood eosinophilia
(>500 cells·µL−1) and 72% had nasal eosinophilia (>5%) [33]. Median FeNO for the whole sample was
33 ppb (IQR 3–79 ppb). Median forced expiratory volume in 1 s (FEV1) in 223 children who underwent
spirometry was 97% predicted (IQR 86–107% pred), of whom 30 (13%) had values below the lower limit
of normal. Median pre-bronchodilator FEV1/forced vital capacity ratio was 91% (IQR 85–97%), median
FEV1 increase after inhaled bronchodilator was 6.4% (IQR 2–14%) and 109 (49%) had a positive
bronchodilator response (increase in FEV1 >12%). IgE was measured in a random sample of 86
participants: total IgE (median 770 kU·L−1, IQR 329–1376 kU·L−1), and mite (D. pteronyssinus and B.
tropicalis) IgE (81% positive). Of the 60 samples tested for specific IgE for cockroach and food allergens,
82% were positive for any allergen.
In univariable analyses (tables 1 and 2), risk factors for recurrence were younger age, early-life severe
respiratory illness, food triggers, previous asthma diagnosis, number and severity of asthma attacks over
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the previous year and lower haemoglobin levels (mean±SD recurrence 12.9±0.87 versus non-recurrence
13.1±0.84, p=0.032). There were no differences in lung function or inflammation parameters (figure 3).
Positivity for IgE specific to any allergen did not vary by recurrence status (recurrence 33 (79%) out of 42
versus non-recurrence 37 (84%) out of 44). The parents of children with recurrence had less specific
asthma knowledge (NAKQ score) (OR 0.91 per 1 point, 95% CI 0.85–0.98 per 1 point) and children had
lower PAQLQ emotional domain scores (OR 0.72 per 1 point, 95% CI 0.55–0.94 per 1 point)
(supplementary table S2). No differences were seen between the two groups for asthma control (ACT and
C-ACT scores) or PAQLQ total, symptoms or activity scores (supplementary table S2). Further results
concerning food triggers for asthma attacks are included in the supplementary material.
The multivariable logistic regression model for risk of severe asthma attack recurrence showed
independent risk factors to be younger age, a previous asthma diagnosis, food triggers, number of
FIGURE 2 Kaplan–Meier curve of
time to first recurrence of severe
asthma attacks. ER: emergency
room.
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FIGURE 1 Recruitment and follow-up of participants.
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parenteral corticosteroid courses for acute asthma in the previous 12 months, and previous eczema
diagnosis (table 3). The AUC of the model was 0.73 (95% CI 0.67–0.79) (c-statistic) and the model
explained 13% of variation. After internal validation (bootstrapping), AUC reduced to 0.72 and R2 to 14%,
indicating little overfitting of regression coefficients.
Table 4 shows the results of multivariable analysis for time to asthma attack recurrence. All children with
⩾2 weeks of follow-up were included in the analysis (n=270). Children of younger age, with an existing
asthma diagnosis, greater number of parenteral corticosteroid courses for acute asthma in the previous
12 months and not living in an urban setting showed a higher rate of recurrent asthma attacks requiring
emergency care. The AUC of the model was 0.65 (95% CI 0.60–0.70) (c-statistic) and overfitting of the
model was estimated as <1% after bootstrapping.
Discussion
We have identified independent predictors for emergency care re-attendance for severe asthma attacks
among asthmatic children in a low-resource setting in a tropical region of coastal Ecuador, to our
knowledge the first such prospective study set in low- and middle-income countries (LMICs) [16]. Having
a previous severe asthma attack was the most reliable predictor of future risk: each acute parenteral
corticosteroid course received during the previous year for acute asthma increased the odds of a
subsequent severe attack by a factor of 1.28. Other factors associated with risk of attack or time to next
attack were similar including younger age (both), an existing asthma (both) or eczema (risk of recurrence)
diagnosis, food triggers (risk of recurrence) and rural residency (time to recurrence). We were unable to
identify a biomarker that could usefully predict future risk of severe attacks.
TABLE 1 Sociodemographic characteristics, personal and family history of 264 participants
followed-up for 6 months or until first asthma attack recurrence, stratified by recurrence
status at 6 months
Total cohort Second asthma attack within 6 months
Yes No p-value
Subjects n 264 121 143
Sociodemographic characteristics
Age years 8 (6–11) 7 (5–10) 9 (7–11) <0.001
Male 59 60 59 0.900
Ethnicity
Afro-Ecuadorian 54 52 55 0.963
Mestizo 43 45 42
White 2 2 1
Other 2 2 2
BMI kg·m−2 16.6 (15.1–19.4) 16.4 (15.0–19.2) 16.9 (15.1–19.7) 0.265
At least one sibling 90 89 91 0.547
Years of study by mother + years of
study by father
24 (18–28) 24 (18–28) 24 (19–29) 0.304
Pets at home 43 45 42 0.708
Second-hand smoke exposure 18 17 21 0.474
Humid household 47 4 51 0.137
Urban setting 66 60 70 0.094
Intense traffic near house 30 30 30 1.000
Monthly household income USD 400 (255–700) 400 (260–700) 350 (250–700) 0.981
Personal and family history
Early-life respiratory illness 49 59 40 0.013
Allergic rhinitis ever 72 74 70 0.490
Allergic rhinitis diagnosis 21 20 21 0.878
Eczema ever 13 14 12 0.713
Eczema diagnosis 4 7 2 0.119
Paternal/maternal asthma 46 53 41 0.175
Paternal/maternal asthma/rhinitis/
eczema
68 70 66 0.788
Data are presented as median (interquartile range) or %, unless otherwise stated. Bold type represents
statistically significant difference (p<0.05). BMI: body mass index.
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Comparison with previous studies and implications
The observed recurrence rate of asthma attacks over 6 months (46%) was higher than reported in similar
studies from UK (37–38%) [34], or US (12–17%) [35], although consistent with our previous findings in
this setting [11]. This and previous studies have identified a history of severe asthma attacks during the
preceding year as a predictor for future asthma attacks [16]. Other predictors identified in univariate
analysis were previous ER attendances, number of parenteral corticosteroid courses and unscheduled
contacts for acute asthma. However, the number of parenteral corticosteroid courses was the only predictor
among these associated with asthma attack recurrence in the multivariable model, probably because of the
specific characteristics of our study setting (low rates of oral corticosteroid prescriptions and variable
degree of severity of attacks).
Among sociodemographic characteristics, younger children had a greater risk of subsequent asthma
attacks, as observed previously in studies undertaken in high-income countries [13, 14]. One possible
explanation is that younger children suffer more from upper respiratory viral infections, such as
rhinovirus, an important trigger for asthma attacks [36]. Children living in the city of Esmeraldas had a
TABLE 2 Asthma characteristics# of 264 participants followed-up for 6 months or until first
asthma attack recurrence, stratified by re-admission status at 6 months
Total
cohort
Second asthma attack within
6 months
Yes No p-value
Subjects n 264 121 143
Wheezing ever 94 98 90 0.021
Wheezing past 12 months 87 93 81 0.003
Attacks past 12 months 3 (2–6) 5 (2–6) 3 (1–5) <0.001
Days since last attack 60 (30–120) 60 (30–120) 60 (30–150) 0.120
Wheezing at night past 12 months
Never 19 16 21 0.424
<1 night per week 1 2 0.7
⩾1 night per week 14 17 11
Only during attacks 66 66 67
Severe attack past 12 months 36 44 30 0.014
Wheezing with exercise
No 36 30 41 0.188
Yes 40 44 37
Only during attacks 24 27 23
Previous asthma diagnosis 64 77 54 <0.001
Triggers 4 (2–6) 4 (3–6) 4 (2–5) 0.117
Food as trigger 37 46 29 0.006
Doctor visit for acute asthma past 12 months
None 15 8 21 <0.001
1–3 49 46 53
4–12 27 32 23
>12 8 14 3
Doctor visit for asthma control past 12 months
None 68 65 71 0.592
1–3 24 26 23
4–12 7 8 7
>12 0.4 0.8 0
ICS treatment 2 0.9 3 0.374
ER visit past 12 months for asthma 76 79 74 0.388
ER asthma visits past 12 months 2 (1–4) 3 (1–6) 2 (0–3) 0.006
Courses of i.v./i.m. corticosteroids in past 12 months
for asthma
0 (0–1) 1 (0–3) 0 (0–1) <0.001
Ever admitted for asthma 25 34 18 0.004
Admitted for asthma in past 12 months 8 12 4 0.034
Ever admitted to ICU for asthma 10 13 7 0.102
Data are presented as % or median (interquartile range), unless otherwise stated. Bold type represents
statistically significant difference (p<0.05). ICS: inhaled corticosteroids; ER: emergency room; i.v./i.m.:
intravenous/intramuscular; ICU: intensive care unit. #: all the variables were measured at baseline, at the
moment of the index asthma attack.
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lower risk of subsequent asthma attacks compared to those from the surrounding rural area, a finding
which has not been described previously. Distance to the emergency care facilities (located in the city)
could have biased the results, with only children with more severe asthma travelling from rural areas to
receive urgent medical attention. The association remained after controlling for variables such as
educational level of parents and socioeconomic factors that have been associated with the risk of asthma
attacks [14]. Two relevant characteristics that have been identified previously as risk factors for repeated
asthma attacks did not predict future events in our study: low socioeconomic status and African ethnicity
[14, 15]. The population in which we worked in Esmeraldas was from poor neighbourhoods with a
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probable high degree of African genetic admixture resulting in a relatively homogeneous cohort and
perhaps reducing power to identify such factors as predictors. A recent study showed that the association
between black ethnicity and paediatric asthma re-admissions was strongly confounded by socioeconomic
factors [37], possibly explaining why Afro-Ecuadorian ethnicity was not a predictor in our study. Further
studies in similar LMICs are necessary to clarify the respective roles of socioeconomic status and ethnicity
as determinants of asthma attack risk.
Asthma in the presence of atopy is associated with other allergic diseases including eczema and
rhinoconjunctivitis. Children with concomitant allergic diseases may have a higher risk of future asthma
attacks [38], as observed here for children with a previous eczema diagnosis. Eczema has been associated
with poor asthma control among children in urban Brazil [38]. Individuals with allergic asthma appear to
be particularly susceptible to virus-induced exacerbations [39], and suppression of allergic mediators
reduces virally mediated attacks [40]. However, in our study we did not observe associations between
allergy markers (blood and nasal eosinophilia, and FeNO) or allergic sensitisation (specific IgE) and risk of
asthma attack recurrence. Further studies are necessary to better understand the nature of this association.
Similarly, there was a greater risk of repeated severe asthma attacks among children describing food as a
trigger (food allergies, colourants or cold foods). A previous population-based study from the UK has
shown an association between food-induced wheeze in children and more frequent attacks of wheeze and
healthcare use [41]. However, the mechanisms involved in food-induced asthma are not well understood
and are not solely immunological, making it difficult to diagnose [42]. This was observed in our cohort,
where there was no association between reported food triggers and a positive IgE to food extracts.
Similarly, most children reported cold drinks/foods (physical agents) as the triggers of their food-induced
asthma.
Predictors of recurrent asthma attacks could be combined into a risk assessment tool to identify children
with good symptom control but at high risk of attacks, a group representing half of those in our study. To
be able to reduce the risk in these children, a complete asthma management package would need to be
implemented: supply of free medication, individualised asthma action plan, training for inhaler technique,
close monitoring of adherence and control of comorbidities and modifiable lifestyle and environmental
risk factors.
TABLE 3 Multivariable logistic regression for risk of emergency room re-attendance for severe
asthma attacks during 6 months follow-up
Crude OR
(95% CI)
p-value Adjusted OR#
(95% CI)
p-value
Age 0.87 (0.79–0.95) 0.001 0.87 (0.79–0.96) 0.006
Previous asthma diagnosis 2.78 (1.62–4.76) <0.001 2.17 (1.19–3.94) 0.011
Number of i.v./i.m. corticosteroid courses
during past 12 months
1.36 (1.15–1.61) <0.001 1.28 (1.08–1.53) 0.006
Food as trigger 2.11 (1.25–3.55) 0.005 1.99 (1.11–3.55) 0.020
Eczema diagnosis 3.26 (0.84–12.6) 0.086 4.22 (1.02–17.54) 0.048
i.v.: intravenous; i.m.: intramuscular. n=264. #: adjusted odds ratios were adjusted for all other variables in
the model.
TABLE 4 Multivariable Cox regression model for emergency room re-attendance for severe
asthma attacks
Crude HR
(95% CI)
p-value Adjusted HR#
(95% CI)
p-value
Age 0.92 (0.87–0.97) 0.002 0.93 (0.88–0.98) 0.009
Previous asthma diagnosis 1.78 (1.26–2.53) 0.001 1.66 (1.15–2.39) 0.007
Number of i.v./i.m. corticosteroid courses
during past 12 months
1.17 (1.10–1.24) <0.001 1.13 (1.06–1.20) <0.001
Urban residence 0.65 (0.47–0.89) 0.007 0.69 (0.50–0.95) 0.023
HR: hazard ratio; i.v.: intravenous; i.m.: intramuscular. n=270. #: adjusted hazard ratios were adjusted for
all other variables in the model.
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Strengths and limitations
Our study had a number of limitations. First, because all children were treated in accordance with local
guidelines, the fact that this cohort of asthmatic children were followed-up, educated about their asthma
and provided a written asthma action plan probably modified their outcomes through improved asthma
knowledge, adherence to treatment and management of attacks. Second, although we initially aimed to
start children on ICS following the Ecuadorian guidelines, the large number of children recruited and
limited human resources available meant it was not possible to monitor the children and their adherence
as closely as we would have liked. Third, the study population has certain characteristics (including
ethnicity, socioeconomic status, asthma knowledge, low proportion of ICS use) that may differ from other
Latin American settings and limit generalisability. Although attendance at ERs for treatment of attacks is
part of the definition of a severe asthma attack according to the American Thoracic Society/European
Respiratory Society statement [1], the severity of disease in our populations may be less than that observed
in high-income settings where better management and alternative treatment options are available.
However, the objective of the study was to identify predictors in a real-world setting to facilitate working
towards a risk assessment tool that can be applied in ERs for any patient presenting with
bronchodilator-responsive wheeze. Strengths of this study were adequate power to identify potential
predictors and a high follow-up rate. The comprehensive questionnaire, inflammatory markers and lung
function measurements were designed to explore a broad range of potential risk factors for asthma attack
recurrence. By including all bronchodilator-responsive wheeze irrespective of previous asthma diagnosis or
lung function parameters, this relatively nonselective sample represented more closely patients with
real-life asthma attending ERs.
Conclusion
In conclusion, we performed a prospective study of children presenting with asthma attacks to ERs in a
resource-poor setting in Ecuador and identified predictors of re-attendance with attacks and time to next
attack. Approximately half of the recruited asthmatic children suffered a subsequent asthma attack within
6 months of follow-up. Several predictors were identified including a previous asthma diagnosis and an
asthma attack during the previous year requiring systemic corticosteroids. A combination of these
predictors could be used as a simple risk-assessment tool in ERs to identify asthmatic children at a higher
risk of recurrent attacks. Such a tool would be extremely useful in LMICs where limited resources should
be targeted towards those most in need of continuing support and treatment. Further studies are now
required to validate our findings in different low-resource settings.
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